Viewing Study NCT06278051


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2025-12-28 @ 10:34 PM
Study NCT ID: NCT06278051
Status: COMPLETED
Last Update Posted: 2024-12-05
First Post: 2024-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Sponsor: Bayer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 21411
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View